Click here for resources and virtual supports during COVID-19 pandemic
 

Boston Medical Center’s Office Based Addiction Treatment (OBAT) Program was established in 2003 and currently serves over 800 patients, making it the largest hospital-based addiction treatment program in New England. The OBAT team treats patients with approved medications for substance use disorders including buprenorphine, injectable buprenorphine, injectable naltrexone, and oral naltrexone. Patients receive specialized treatment for their substance use disorder integrated within a primary care setting, allowing all their medical needs to be addressed by a team of providers. The OBAT Program has been recognized nationally and replicated within many outpatient settings, including primary care, family medicine, behavioral health, and OB/Gyn practices, among others.

Derrek Anderson speaks about how the program helped him end 30 years of heroin use.

 

    Contact Us

    725 Albany Street, Boston, MA 02118
    5th Floor, Suite 5B
    Shapiro Center
    617.414.4123 / 617.414.4107
    Monday - Thursday 8:00 AM - 8:00 PM; Friday 8:00 AM - 12:00 PM

    Conditions We Treat

    Treatments & Services

    The BMC OBAT Program provides the following services to patients:
    • Treatment for all types of Substance Use Disorders, including opioid, alcohol, benzodiazepine, and stimulant use disorders
    • Trained addiction experts including nurses, physicians, nurse practitioners, social workers, psychiatrists, patient care coordinators, medical assistants, and recovery coaches
    • Medications for Opioid Use Disorder (MOUD): buprenorphine (Suboxone), injectable buprenorphine (Sublocade), and naltrexone (Vivitrol, Revia)
    • Same-day medication access
    • Direct telephone access to the nursing team
    • Compassionate and non-judgmental care
    • Harm reduction services and resources
    • Specialized services to justice-involved individuals, adolescents, pregnant and post-partum women, and those with brain injuries
    • Assistance accessing social supports and other benefits (e.g., food, IDs, employment, insurance)
    • Behavioral health and psychiatric services
    • Access to short- and long-term birth control
    • Screening and treatment options for HIV; Hepatitis A, B, and C; and Sexually Transmitted Infections (STI)    
    • Overdose education and access to naloxone (Narcan)

    Our Team

    Program Leadership

    Colleen Labelle, MSN, RN-BC, CARN
    Program Director

    Jason Worcester, MD
    Medical Director

    Lexie Bergeron, MPH, LCSW
    Director of Operations

    Nurse Care Manager Team

    Christie Conners, BSN, RN
    Nurse Care Manager

    Stacey Dobrowolski, BSN, RN, CARN
    Nurse Care Manager

    Eileen Grassie, BSN, RN
    Nurse Care Manager

    Darlene Justal, BSN, RN
    Nurse Care Manager

    Michelle Lima, BSN, RN, CARN
    Nurse Care Manager

    Sarah McKeon, BSN, RN
    Nurse Care Manager

    Carla Merlos, BSN, RN
    Nurse Care Manager

    Jill Shaw, RN, CARN
    Nurse Care Manager

    Isela Wellington, BSN, RN
    Nurse Care Manager

    Susan Dickerman
    Patient Care Coordinator

    Chris Kennedy
    Patient Care Coordinator

    Antoneta Zyba
    Medical Assistant

    Stacey Mitchell
    OBAT Triage Coordinator

    Stimulant Treatment and Recovery Team (START)

    Marielle C Baldwin, MD, MPH
    Medical Director, START 

    Anne Claude, BSN, RN
    Nurse Care Manager, START

    Faith Puleikis
    Program Coordinator, START

    Katie Raftery
    Program Coordinator, START

    Medical Prescribers

    Daniel Alford, MD, MPH
    Physician, OBAT

    Jonathan P Berz, MD
    Physician, OBAT

    Joseph F Boyle, MD
    Physician, OBAT

    Robert D Bruce, MD
    Physician, OBAT

    Pablo A Buitron de la Vega, MD
    Physician, OBAT

    Sheila E Chapman, MD
    Physician, OBAT

    Shaleen Chakyayil, MD
    Physician, OBAT

    Chloe Ciccariello, MD
    Physician, OBAT

    Ricardo Cruz, MD
    Physician, OBAT

    Amy Fitzpatrick, MD
    Physician, OBAT

    Elke P Ganz, NP
    Nurse Practitioner, OBAT

    Sandra S Looby-Gordon, MD
    Physician, OBAT

    Alice Grant, FNP-C, MSN
    Nurse Practitioner, OBAT

    Emily E Hurstak, MD, MPH
    Physician, OBAT

    Theresa W Kim, MD
    Physician, OBAT

    Sarah L Kimball, MD
    Physician, OBAT

    Andrea Jodat, NDP, FNP-BC
    Nurse Practitioner, OBAT

    Jordana Laks, MD, MPH
    Physician, OBAT

    Karen E Lasser, MD
    Physician, OBAT

    Kristin Lee, MD
    Physician, OBAT

    Vasudev C Mandyam, MD
    Physician, OBAT

    Juhee C McDougal, MD
    Physician, OBAT

    Christine A Pace, MD
    Physician, OBAT

    Susan L Phillips, MD
    Physician, OBAT

    Annie L Potter, MSN, MPH, NP
    Nurse Practitioner, OBAT

    Christine A Prifti, MD
    Physician, OBAT

    Catherine A Rich, MD
    Physician, OBAT

    Margot P Rogers, MD
    Physician, OBAT

    Jeffrey H Samet, MD, MA, MPH
    Physician, OBAT

    Lucy B Shulson, MD
    Physician, OBAT

    Jennifer R Siegal, MD
    Physician, OBAT

    Jessica L Taylor, MD
    Physician, OBAT

    Kristin F Wason, MSN, NP-C
    Nurse Practitioner, OBAT

    Zoe M Weinstein, MD
    Physician, OBAT

    Theresa C Weir, NP
    Nurse Practitioner, OBAT

     

    Provider Resources

    Training and Technical Assistance

    BMC's OBAT Training and Technical Assistance (TTA) team supports over 40 community health centers across Massachusetts and advises health care teams locally and nationwide on how to implement this model of addiction treatment, now known as the Massachusetts Model, in their own organizations. 

    Additional Information

    Research Overview

    Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness - Fine DR, Lewis E, Weinstock K, Wright J, Gaeta JM, Baggett TP. [published correction appears in JAMA Netw Open. 2021 Aug 2;4(8):e2128112]. JAMA Netw Open. 2021;4(3):e210477. Published 2021 Mar 1. doi:10.1001/jamanetworkopen.2021.0477

    Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. - Weinstein ZM, Gryczynski G, Cheng DM, et al. Drug Alcohol Depend. 2018;189:166-171. doi:10.1016/j.drugalcdep.2018.05.010

    Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse - Wason K, Potter A, Alves J, et al. . J Nurs Adm. 2021;51(9):424-429. doi:10.1097/NNA.0000000000001041

    Residency and Fellowship Information

    Addiction Medicine Fellowship

    The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.

    The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more